Cargando…

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19

Detalles Bibliográficos
Autores principales:	Agusti, Alvar, Torres, Ferran, Faner, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040539/ https://www.ncbi.nlm.nih.gov/pubmed/33844998 http://dx.doi.org/10.1016/S2213-2600(21)00171-5

Ejemplares similares

Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
por: Agustí, Alvar, et al.
Publicado: (2022)

Inhaled corticosteroids for the treatment of COVID-19
por: Bafadhel, Mona, et al.
Publicado: (2022)

Inhaled budesonide for early treatment of COVID-19
por: Choi, Jae Chol, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: San-Juan, Rafael, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: Zeitlinger, Markus, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19 – Authors' reply
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Are women with asthma at increased risk for severe COVID-19?
por: Fernando, Mario, et al.
Publicado: (2021)

The use of inhaled corticosteroids in early-stage COVID-19
por: Mangin, Dee, et al.
Publicado: (2021)

Is inhaled budesonide an effective treatment for patients with mild early symptoms of COVID-19?
por: Kareemi, Hashim, et al.
Publicado: (2021)

When Harry Met Sally, or When Machine Learning Met Chronic Obstructive Pulmonary Disease
por: Agusti, Alvar, et al.
Publicado: (2020)

Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
por: Nicolau, Dan V, et al.
Publicado: (2020)

From systems biology to P4 medicine: applications in respiratory medicine
por: Noell, Guillaume, et al.
Publicado: (2018)

Inhalatives Budesonid zur Therapie bei COVID-19
por: Kluge, S., et al.
Publicado: (2021)

Comment on Casiraghi et al. “Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis” 2020, 12, 211
por: Zur, Eyal
Publicado: (2020)

Inhaled corticosteroids: not just for asthma, but for COVID-19?
por: Liew, Felicity, et al.
Publicado: (2022)

Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006)

Gold 2023: Highlights for primary care
por: Agustí, Alvar, et al.
Publicado: (2023)

Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?
por: Singh, Dave, et al.
Publicado: (2020)

COVID-19 and inhaled corticosteroids—another piece in an expanding puzzle
por: Schultze, Anna, et al.
Publicado: (2021)

Efficacy of inhaled budesonide for the treatment of severe equine asthma
por: Lavoie, J. P., et al.
Publicado: (2018)

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Comment on “Laboratory Measurement and Analysis of the Deteriorated Layer Permeability Coefficient of Soil–Cement Deteriorated in a Saline Environment”
por: Neves, Rui
Publicado: (2020)

Reply to Guo et al.
por: Wang, Gang, et al.
Publicado: (2023)

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
por: Halpin, David M G, et al.
Publicado: (2020)

Systemic Inflammatory Response to Smoking in Chronic Obstructive Pulmonary Disease: Evidence of a Gender Effect
por: Faner, Rosa, et al.
Publicado: (2014)

High-dose budesonide for early COVID-19
por: Lipworth, Brian, et al.
Publicado: (2021)

High-dose budesonide for early COVID-19
por: Berezowski, Ivan, et al.
Publicado: (2021)

Comparison of the Efficacy of Budesonide Nebulizer Suspension and Budesonide Inhalation Suspension in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Emami Ardestani, Mohammad, et al.
Publicado: (2018)

Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19
por: Cruz, Tamara, et al.
Publicado: (2023)

Preventing clinically important deterioration with single-inhaler triple therapy in COPD
por: Naya, Ian, et al.
Publicado: (2018)

Cellular Senescence in Lung Fibrosis
por: Hernandez-Gonzalez, Fernanda, et al.
Publicado: (2021)

Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks
por: Yanagida, Noriyuki, et al.
Publicado: (2015)

Hydroxychloroquine in the prevention of COVID-19 mortality
por: Jorge, April
Publicado: (2021)

Network medicine analysis of COPD multimorbidities
por: Grosdidier, Solène, et al.
Publicado: (2014)

Prevention and control strategies for the diagnosis and treatment of cancer patients during the COVID-19 pandemic
por: Tan, Juan, et al.
Publicado: (2020)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
por: Dyer, Matthew J, et al.
Publicado: (2006)

Early treatment to prevent progression of SARS-CoV-2 infection
por: Cohen, Myron S
Publicado: (2022)

The Effect of Inhaled Budesonide on the Prevention of Chronic Lung Disease in Premature Neonates with Respiratory Distress Syndrome
por: Sadeghnia, Alireza, et al.
Publicado: (2018)

Early-phase clinical trials in a pandemic: learning from the response to COVID-19
por: Horsley, Alex, et al.
Publicado: (2022)

Implementing systems medicine within healthcare
por: Kirschner, Marc, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m9jic7mpnsj00vmk5gpt2h4gmn